Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations

被引:104
作者
Seghaye, MC
Duchateau, J
Bruniaux, J
Demontoux, S
Bosson, C
Serraf, A
Lecronier, G
Mokhfi, E
Planche, C
机构
[1] CTR CHIRURG MARIE LANNELONGUE,DEPT PEDIAT CARDIAC INTENS CARE,LE PLESSIS ROBINS,FRANCE
[2] CTR CHIRURG MARIE LANNELONGUE,DEPT PEDIAT CARDIAC SURG,LE PLESSIS ROBINS,FRANCE
[3] HOP UNIV BRUGMANN,DEPT IMMUNOL,BRUSSELS,BELGIUM
[4] HOP UNIV ST PIERRE,B-1000 BRUSSELS,BELGIUM
关键词
D O I
10.1016/S0022-5223(96)70306-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate cytokine balance related to cardiopulmonary bypass, we prospectively investigated 11 infants undergoing cardiac operations for congenital heart disease, Proinflammatory cytokines (tumor necrosis factor-alpha and interleukin-8) and the antiinflammatory cytokine interleukin-10 were measured at multiple time points before, during, and after bypass, Tumor necrosis factor-alpha and interleukin-8 values were within normal range before the operation, These values increased significantly during bypass, reaching their peaks after protamine administration (tumor necrosis factor-alpha, 133.6 +/- 124.9 pg/ml; mean +/- standard deviation; p < 0.005) and 2 hours after termination of the procedure (interleukin-8, 92.1 +/- 44.1 pg/ml; p < 0.01), Tumor necrosis factor-alpha and interleukin-8 equaled normal prebypass values from the first postoperative day on, Interleukin-10 levels were within normal range before the operation and were already significantly increased 10 minutes after initiation of bypass (interleukin-10, 39.4 +/- 34.3 pg/ml;p < 0.05), These levels remained elevated throughout the procedure but returned to normal after protamine administration, A second significant release of interleukin-10 occurred from the early postoperative period on, reaching its peak 24 hours after termination of cardiopulmonary bypass (interleukin-10, 351.6 +/- 304.0 pg/ml; p < 0.01), Interleukin-10 values were normal on the second postoperative day in all patients, Interleukin-10 kinetics showed an inverse pattern compared with tumor necrosis factor-alpha and interleukin-8. This difference suggests an interplay between proinflammatory and antiinflammatory cytokines released during and after cardiopulmonary bypass, Interleukin-10 levels measured 4 and 24 hours after bypass strongly correlated with the degree of hypothermia during bypass (Spearman's correlation coefficient, -0.77 [p < 0.01] and -0.89 [p < 0.0005], respectively); these levels did not correlate with duration of bypass and aortic crossclamping, however, This result suggests that besides immunologically mediated production of interleukin-10, hypothermia itself could modulate interleukin-10 production, In conclusion, this study demonstrates interleukin-10 production, in addition to interleukin-8 and tumor necrosis factor-alpha synthesis, in response to cardiopulmonary bypass in infants, Interleukin-10 could play a protective role by down-regulating proinflammatory cytokine release during and after cardiopulmonary bypass.
引用
收藏
页码:545 / 553
页数:9
相关论文
共 31 条
[1]   ROLE OF CYTOKINES IN THE PATHOGENESIS OF CARDIOPULMONARY-INDUCED MULTISYSTEM ORGAN FAILURE [J].
CASEY, LC .
ANNALS OF THORACIC SURGERY, 1993, 56 (05) :S92-S96
[2]   CIRCULATING ENDOTOXIN AND TUMOR-NECROSIS-FACTOR DURING PEDIATRIC CARDIAC-SURGERY [J].
CASEY, WF ;
HAUSER, GJ ;
HANNALLAH, RS ;
MIDGLEY, FM ;
KHAN, WN .
CRITICAL CARE MEDICINE, 1992, 20 (08) :1090-1096
[3]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[4]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699
[5]   HIGH-LEVELS OF INTERLEUKIN-10 DURING THE INITIAL PHASE OF FULMINANT MENINGOCOCCAL SEPTIC SHOCK [J].
DERKX, B ;
MARCHANT, A ;
GOLDMAN, M ;
BIJLMER, R ;
VANDEVENTER, S .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :229-232
[6]   INTERLEUKIN-8 RELEASE AND NEUTROPHIL DEGRANULATION AFTER PEDIATRIC CARDIOPULMONARY BYPASS [J].
FINN, A ;
NAIK, S ;
KLEIN, N ;
LEVINSKY, RJ ;
STROBEL, S ;
ELLIOTT, M .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (02) :234-241
[7]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[8]  
FRERING B, 1994, J THORAC CARDIOV SUR, V108, P636
[9]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550
[10]  
HAEFFNERCAVAILLON N, 1989, J THORAC CARDIOV SUR, V98, P1100